LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 7 of 15: Mean cell count and mean growth rate across all replicates. - Dataset (ID:20243)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Mean Relative Cell Count | Standard Error of the Mean for Relative Cell Count | Mean Relative Growth Rate | Standard Error of the Mean for Relative Growth Rate |
---|---|---|---|---|---|---|---|---|
SK-BR-3 | PHA-793887 | 10.0 | uM | LJP6 | 0.2470 | 0.0261 | -0.2588 | 0.1116 |
SK-BR-3 | PI103 | 10.0 | uM | LJP6 | 0.3289 | 0.0250 | -0.1204 | 0.0914 |
SK-BR-3 | QL-X-138 | 10.0 | uM | LJP6 | 0.2820 | 0.0308 | -0.2006 | 0.1132 |
SK-BR-3 | QL-XII-47 | 10.0 | uM | LJP6 | 0.2506 | 0.0390 | -0.2463 | 0.0760 |
SK-BR-3 | Radicicol | 10.0 | uM | LJP6 | 0.2925 | 0.0398 | -0.1715 | 0.0078 |
SK-BR-3 | Saracatinib | 10.0 | uM | LJP6 | 0.5084 | 0.0123 | 0.1803 | 0.0550 |
SK-BR-3 | Selumetinib | 10.0 | uM | LJP6 | 0.9633 | 0.0150 | 0.9360 | 0.0276 |
SK-BR-3 | Sirolimus | 10.0 | uM | LJP6 | 0.5933 | 0.0049 | 0.3211 | 0.0480 |
SK-BR-3 | Sorafenib | 10.0 | uM | LJP6 | 0.5179 | 0.0603 | 0.1855 | 0.1413 |
SK-BR-3 | Torin1 | 10.0 | uM | LJP6 | 0.2884 | 0.0176 | -0.1894 | 0.0986 |
SK-BR-3 | Withaferin A | 10.0 | uM | LJP6 | 0.2653 | 0.0053 | -0.2256 | 0.0812 |
SK-BR-3 | WYE-125132 | 10.0 | uM | LJP6 | 0.3666 | 0.0212 | -0.0560 | 0.0753 |
SK-BR-3 | XMD11-50 | 10.0 | uM | LJP6 | 0.4340 | 0.0210 | 0.0525 | 0.0907 |
SK-BR-3 | Y39983 | 10.0 | uM | LJP6 | 0.3368 | 0.0160 | -0.1086 | 0.0920 |
BT-20 | Afatinib | 0.04 | uM | LJP6 | 0.7512 | 0.0142 | 0.6398 | 0.0186 |